- Recommendation ID
- NG145/6
- Question
What is the clinical and cost effectiveness of different durations of antithyroid drug regimens for people with T3 thyrotoxicosis due to Graves' disease?
- Any explanatory notes
(if applicable)
Source guidance details
- Comes from guidance
- Thyroid disease: assessment and management
- Number
- NG145
- Date issued
- November 2019
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 30/11/2019 |